Our findings identify KLF2 as a key regulator of megakaryopoiesis, expanding our understanding of the molecular mechanisms in megakaryocytic differentiation and yielding possible new ideas for the intervention in thrombocytopenia. This evidence concerns the gene KLF2 and Thrombocytopenia.